Literature DB >> 12405890

Gestational diabetes in Victoria in 1996: incidence, risk factors and outcomes.

Christine A Stone1, Kylie A McLachlan, Jane L Halliday, Peter Wein, Christine Tippett.   

Abstract

OBJECTIVES: To describe the epidemiology of gestational diabetes mellitus (GDM) in Victoria. STUDY
DESIGN: Population study of all women having singleton births in Victoria in 1996.
METHODS: Probabilistic record linkage of routinely collected data and capture-recapture techniques to provide an estimate of the incidence of GDM. MAIN OUTCOME MEASURES: Risk factors for and the adverse outcomes associated with GDM compared with the non-diabetic population by univariate and multivariate analysis.
RESULTS: The estimated incidence of GDM was 3.6% (95% confidence interval [CI], 3.60%-3.64%). GDM is associated with women who are older, Aboriginal, non-Australian born, or who give birth in a larger hospital. The adverse outcomes associated with GDM pregnancies were hypertension/pre-eclampsia (adjusted odds ratio [OR], 1.6; 95% CI, 1.4-1.9), hyaline membrane disease (1.6; 1.2-2.2), neonatal jaundice (1.4; 1.2-1.7) and macrosomia (2.0; 1.8-2.3). Interventions during childbirth were also associated with GDM - for example, induction of labour (3.0; 2.7-3.4) and caesarean section (1.7; 1.6-1.9).
CONCLUSION: Women with GDM had increased rates of hypertension, pre-eclampsia, induced labour, and interventional delivery. Their offspring had a higher risk of macrosomia, neonatal jaundice and hyaline membrane disease.

Entities:  

Mesh:

Year:  2002        PMID: 12405890     DOI: 10.5694/j.1326-5377.2002.tb04916.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

Review 1.  The increasing prevalence of diabetes in pregnancy.

Authors:  Kelly J Hunt; Kelly L Schuller
Journal:  Obstet Gynecol Clin North Am       Date:  2007-06       Impact factor: 2.844

Review 2.  The association between gestational diabetes and stillbirth: a systematic review and meta-analysis.

Authors:  Patricia Lemieux; Jamie L Benham; Lois E Donovan; Nadia Moledina; Christy Pylypjuk; Jennifer M Yamamoto
Journal:  Diabetologia       Date:  2021-10-21       Impact factor: 10.122

3.  A Comprehensive Systematic Review of Data Linkage Publications on Diabetes in Australia.

Authors:  Ngan T T Dinh; Ingrid A Cox; Barbara de Graaff; Julie A Campbell; Brian Stokes; Andrew J Palmer
Journal:  Front Public Health       Date:  2022-05-25

4.  Pregnancy complications among women born preterm.

Authors:  Ariane Boivin; Zhong-Cheng Luo; François Audibert; Benoit Mâsse; Francine Lefebvre; Réjean Tessier; Anne Monique Nuyt
Journal:  CMAJ       Date:  2012-09-24       Impact factor: 8.262

5.  Socio-cultural disparities in GDM burden differ by maternal age at first delivery.

Authors:  Marion Abouzeid; Vincent L Versace; Edward D Janus; Mary-Ann Davey; Benjamin Philpot; Jeremy Oats; James A Dunbar
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

6.  A population-based observational study of diabetes during pregnancy in Victoria, Australia, 1999-2008.

Authors:  Marian Abouzeid; Vincent L Versace; Edward D Janus; Mary-Ann Davey; Benjamin Philpot; Jeremy Oats; James A Dunbar
Journal:  BMJ Open       Date:  2014-11-14       Impact factor: 2.692

Review 7.  Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors.

Authors:  Ying Yang; Na Wu
Journal:  Front Cardiovasc Med       Date:  2022-02-16

8.  Representations and coverage of non-English-speaking immigrants and multicultural issues in three major Australian health care publications.

Authors:  Pamela W Garrett; Hugh G Dickson; Anna Klinken Whelan; Linda Whyte
Journal:  Aust New Zealand Health Policy       Date:  2010-01-03

Review 9.  Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United States.

Authors:  Catherine Chamberlain; Bridgette McNamara; Emily D Williams; Daniel Yore; Brian Oldenburg; Jeremy Oats; Sandra Eades
Journal:  Diabetes Metab Res Rev       Date:  2013-05       Impact factor: 4.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.